Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Long-Term Investments (2016 - 2025)

IGC Pharma (IGC) has disclosed Long-Term Investments for 12 consecutive years, with $25000.0 as the latest value for Q3 2025.

  • Quarterly Long-Term Investments changed N/A to $25000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $25000.0 through Sep 2025, changed N/A year-over-year, with the annual reading at $12000.0 for FY2021, 9.09% up from the prior year.
  • Long-Term Investments for Q3 2025 was $25000.0 at IGC Pharma, up from $11000.0 in the prior quarter.
  • The five-year high for Long-Term Investments was $25000.0 in Q3 2025, with the low at $11000.0 in Q2 2021.